Vigil Neuroscience (VIGL) Financials

$8.05

$0.00 (0.00%)

As on 05-Aug-2025 09:30EDT

Market cap

$376 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

9.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	0.45	--	--	--	--	--
Cost of Revenue	0.46	0.45	0.40	1.01	0.35	--
Gross Profit	-0.01	-0.45	-0.40	-1.01	-0.35	--
Operating Expenses	96.75	89.23	88.87	68.88	42.41	6.29
Operating Profit (EBIT)	-96.75	-89.68	-88.87	-68.88	-42.41	-6.29
Other Income	--	--	--	0.58	--	--
Profit before Tax	-92.17	-84.26	-82.64	-68.31	-43.28	-28.55
Provision for Tax	--	--	--	-0.58	-0.03	-0.01
Profit after Tax (Net Income)	-92.17	-84.26	-82.64	-67.73	-43.25	-28.55
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-68.31	-43.28	-57.09

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	41.26	71.64	116.25	189.08	92.50	-28.28
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	11.33	11.91	12.95	2.12	162.00	51.58
Current Liabilities	34.11	34.15	11.66	11.31	9.88	2.00
Total Liabilities	120.81	117.69	140.86	200.39	102.44	25.30

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	16.41	17.11	18.95	2.59	4.96	--
Current Assets	70.29	100.58	121.91	197.81	97.48	25.30
Total Assets	120.81	117.69	140.86	200.39	102.44	25.30
Total Debt*	12.44	12.95	13.85	0.18	0.94	0.00
Net Current Assets	36.18	66.44	110.25	186.49	87.60	23.30

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-51.22	-70.36	-65.15	-39.35	-5.18
Cash Flow from Investing Activities	--	8.76	-65.14	-0.92	-0.20	-0.50
Cash from Financing Activities	--	29.49	0.89	161.26	107.75	29.83
Net Cash Inflow / Outflow	--	--	--	95.19	--	--

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-2.09	-2.02	-2.13	-1.76	-1.53	-1.36
Cash EPS ($)	--	-2.01	-2.12	-1.76	-1.53	-1.36
Adjusted Book Value ($)	--	1.72	2.99	4.91	3.27	-1.34
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.23	-1.81	-1.69	-1.39	-0.25
Free Cash Flow per Share ($)	--	-1.23	-1.83	-1.72	-1.40	-0.27

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-78.49	-51.75	-47.92	-132.78	--
ROE (%)	-163.28	-89.69	-54.13	-48.10	-134.71	--
ROA (%)	-76.79	-65.18	-48.43	-44.73	-67.72	--
EBIT Margin (%)	-21,199.78	--	--	--	--	--
Net Margin (%)	-20,390.49	--	--	-11,697.06	--	--
Cash Profit Margin (%)	-0.04	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-76.63	--	--	--	--	--
EBIT Growth (%)	-6.39	5.19	-29.01	-62.43	-3.11	--
Net Profit Growth (%)	-9.93	-1.96	-22.02	-56.58	-51.52	--
EPS Growth (%)	1.39	0.05	-0.21	-0.15	-0.13	--
Book Value Growth (%)	-58.79	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.84	-1.59	-7.10	--	--
Price / Book Value	9.11	0.99	1.13	2.54	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.16	0.17	-0.31	-4.28	--	--
Close Price ($)	7.95	1.70	3.38	12.50	--	--
High Price ($)	7.96	6.06	12.96	18.27	--	--
Low Price ($)	1.31	1.49	2.85	2.18	--	--
Market Cap ($ Cr)	375.71	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.18	0.12	0.00	0.01	0.00
Short term debt to equity ratio	0.05	0.01	0.01	0.00	0.02	--
Current Ratio	2.06	2.95	10.45	17.49	9.87	12.68
Quick Ratio	2.06	--	--	16.55	--	--
Interest Coverage	--	--	--	-883.13	-0.98	--

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	123.45	--	--	--	--	--
Asset Turnover	0.00	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	9,664.02	3,817.77	--	--
Payable days	--	1,577.51	1,779.56	1,070.25	2,691.20	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.